Browse by Glasgow Author (original) (raw)

Number of items: 3.

2022

Parry, Narissa, Busch, Caroline, Aßmann, Victoria, Cassels, Jennifer ORCID logoORCID: https://orcid.org/0009-0004-7138-9946, Hair, Alan, Helgason, G. Vignir ORCID logoORCID: https://orcid.org/0000-0003-1616-132X, Wheadon, Helen ORCID logoORCID: https://orcid.org/0000-0001-9902-3170 and Copland, Mhairi ORCID logoORCID: https://orcid.org/0000-0002-7655-016X(2022)BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia. Cell Death Discovery, 8, 457. (doi: 10.1038/s41420-022-01211-1) (PMID:36379918) (PMCID:PMC9666353)

2021

Parry, Narissa, Wheadon, Helen ORCID logoORCID: https://orcid.org/0000-0001-9902-3170 and Copland, Mhairi ORCID logoORCID: https://orcid.org/0000-0002-7655-016X(2021)The application of BH3 mimetics in myeloid leukemias. Cell Death and Disease, 12, 222. (doi: 10.1038/s41419-021-03500-6) (PMID:33637708) (PMCID:PMC7908010)

2020

Kinstrie, R. et al. (2020)CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy. Leukemia, 34(6), pp. 1613-1625. (doi: 10.1038/s41375-019-0684-5) (PMID:31896780) (PMCID:PMC7272220)

This list was generated on Tue Feb 17 00:14:07 2026 GMT.